Literature DB >> 2921133

Ten-year follow-up of esophageal cancer treated by radical radiation therapy: analysis of 869 patients.

D R Sun1.   

Abstract

The 10-year follow-up 869 patients with esophageal cancer treated by radiation is presented with emphasis on treatment methods, and results. The survival rates declined as the staging of the lesion advanced (p less than 0.01). The results improve with the shortening of the lesion (p less than 0.005) in the absence of metastasis. The effect of radiation is closely related to the dose given. A booster dose of 5-10 Gy in addition to the conventional curative dose of 60-69 Gy may increase the long-term survival of this cancer. The causes of the external irradiation failure are mainly recurrence and out of control of disease. Also, the author has discussed the occurrence and prevention of some complications.

Entities:  

Mesh:

Year:  1989        PMID: 2921133

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  21 in total

Review 1.  Squamous cell carcinoma of the oesophagus: 10 years on.

Authors:  G A Khoury
Journal:  Ann R Coll Surg Engl       Date:  1991-01       Impact factor: 1.891

2.  Chemoradiotherapy for treatment of esophageal cancer in Japan: current status and perspectives.

Authors:  Kohei Shitara; Kei Muro
Journal:  Gastrointest Cancer Res       Date:  2009-03

3.  Update: modern approaches to the treatment of localized esophageal cancer.

Authors:  James Welsh; Arya Amini; Anna Likhacheva; Jeremy Erasmus J; Daniel Gomez; Marta Davila; Reza J Mehran; Ritsuko Komaki; Zhongxing Liao; Wayne L Hofstetter; Jeffrey Lee H; Manoop S Bhutani; Jaffer A Ajani
Journal:  Curr Oncol Rep       Date:  2011-06       Impact factor: 5.075

4.  The effect of neoadjuvant chemoradiotherapy on airway colonization and postoperative respiratory complications in patients undergoing oesophagectomy for oesophageal cancer.

Authors:  Reza Bagheri; Mohammad Taghi RajabiMashhadi; Kiyarash Ghazvini; Amir Asnaashari; Ali Zahediyan; Mehdi Abasi Sahebi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-03-05

Review 5.  Adjuvant therapies for cancer of the thoracic esophagus.

Authors:  T Nishihira; T Nakano; S Mori
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

6.  Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer.

Authors:  Maria Wolf; Franz Zehentmayr; Maximilian Niyazi; Ute Ganswindt; Wolfgang Haimerl; Michael Schmidt; Dieter Hölzel; Claus Belka
Journal:  Strahlenther Onkol       Date:  2010-06-24       Impact factor: 3.621

7.  Does pre-operative estimation of oesophageal tumour metabolic length using 18F-fluorodeoxyglucose PET/CT images compare with surgical pathology length?

Authors:  Reubendra Jeganathan; James McGuigan; Frederick Campbell; Thomas Lynch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-12-16       Impact factor: 9.236

Review 8.  Esophageal cancer, early disease: diagnosis and current treatment.

Authors:  H D Becker
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

9.  Catch me if you can--the use of image guidance in the radiotherapy of an unusual case of esophageal cancer.

Authors:  Alexandra D Jensen; Christian Grehn; Anna Nikoghosyan; Christian Thieke; Robert Krempien; Peter E Huber; Jürgen Debus; Marc W Münter
Journal:  Strahlenther Onkol       Date:  2009-08-28       Impact factor: 3.621

10.  Downstaging of esophageal cancer after preoperative radiation and chemotherapy.

Authors:  S B Vogel; W M Mendenhall; M D Sombeck; R Marsh; E R Woodward
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.